论文部分内容阅读
作者在219名疑有十二指肠、胰腺或肝病的患者中进行了234次十二指肠窥镜检查及胰胆管造影。其中18次只观察胆道口壶腹未插管;17次试图插管多次但未成功;25次行选择性胆管造影;余174次行胰管造影,同时有或无胆道显影。所用造影剂为60％泛影葡胺或甲基泛影酸350(Isopaque 350)。在紧接检查前、后、检查后6小时及次日抽血,并在检查后一周内隔日1次抽血,测定血清淀粉酶总活性以及唾液和胰的淀粉酶同功酶活性。 234次检查中,203次检查前血清胰淀粉酶同功酶活性正常。其中15次单做窥镜检查,16次看到壶腹但
The authors performed 234 endoscopic duodenoscopy and cholangiopancreatography in 219 patients with suspected duodenal, pancreatic or hepatic diseases. Among them, only 18 cases were observed intubation of the ampulla of the cholangiocarcinoma; 17 times of unsuccessful intubation attempts; 25 cases of selective cholangiography; and 174 cases of pancreatic duct angiography with or without biliary development. The contrast medium used was 60% diatrizoate or Isopaque 350 (Isopaque 350). Immediately prior to, after, 6 hours after the test and the next day after the test blood, and within the week after the test blood was taken every other day to measure the total serum amylase activity and saliva and pancreatic amylase isozyme activity. 234 tests, 203 tests before serum pancreatic amylase isozyme activity. Of which 15 single endoscopy, 16 times to see the ampulla